I

ITF Therapeutics

Develops and commercializes rare-disease therapies

Chief of Staff

Business OperationsConfirmed live in the last 24 hours
Full-timeConcord, MA, USA$270k - $295kIn-person

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 12 years of relevant experience in biotechnology or pharmaceuticals, management consulting, strategy, business operations, program or portfolio leadership, or related roles, including significant experience operating with senior executives.
  • Demonstrated experience operating at the executive and Board level.
  • Track record designing and running planning and governance processes in a scaling organization.
  • Exceptional executive communication skills, including executive-level writing and the ability to produce Board-ready material independently.
  • Strong analytical and strategic thinking skills, with the ability to simplify complexity.
  • Demonstrated ability to influence and collaborate across diverse teams without formal authority.
  • Passion for rare disease innovation and patient impact.

Responsibilities

  • Serve as a trusted thought partner and sounding board to the President, offering an independent point of view and helping frame key strategic and operating questions.
  • Identify, structure, and drive resolution of complex or ambiguous enterprise issues by developing options, trade-offs, and recommendations to support timely decision-making.
  • Prepare the President for high-stakes internal and external moments, including Board meetings, leadership discussions, and organizational communications.
  • Partner with the President on enterprise communications, translating strategy, decisions, and priorities into clear narratives for employees, leadership, the Board, and global stakeholders.
  • Model company values and champion a culture of transparency, accountability, and patient-centered decision-making.
  • Work closely with the Group CEO's chief of staff to coordinate key business processes, stay informed about key business issues, and shepherd organizations in addressing opportunities and issues as needed.
  • Own the design and execution of planning cadences, including long-range planning, annual strategic planning, and the Annual Operating Plan.
  • Lead enterprise goal setting, translating strategy into focused priorities for leadership commitment and organizational execution.
  • Ensure functional plans align to enterprise priorities, surfacing gaps, dependencies, and conflicts early.
  • Partner with finance and functional leaders to integrate strategic priorities, resource requirements, and financial constraints into enterprise planning; surface competing demands and trade-offs for leadership decision-making and ensure agreed resource decisions are reflected in operating plans.
  • Own the enterprise business performance framework and review cadence, partnering with business and functional leaders to define critical performance measures and ensure consistent, decision-useful reporting.
  • Lead high-priority enterprise initiatives when ownership spans functions, significant ambiguity exists, or additional enterprise leadership is required.
  • Structure complex cross-functional work into clear objectives, workplans, decisions, dependencies, and accountabilities, and drive execution through completion.
  • Identify breakdowns or inefficiencies in ways of working as the company scales and drive solutions, coordinating with the Group CEO's chief of staff when processes extend beyond the US environment.
  • Establish permanent ownership and operating mechanisms for initiatives when mature enough to transition into the organization.
  • Own the leadership team operating rhythm, including agendas, pre-reads, facilitation, decision capture, and follow-through.
  • Design and evolve the enterprise governance model, defining forums, accountabilities, decisions, participants, and escalation paths.
  • Prepare the President and leadership team for Board and Joint Steering Committee meetings, owning materials, narrative, and stakeholder pre-alignment.
  • Ensure leadership forums are decision-oriented, with clear decision rights, high-quality pre-work, recommendations, and follow-through.
  • Lead leadership team offsites from objective-setting and design through facilitation and outputs.
  • Establish and maintain enterprise standards, templates, and operating mechanisms, simplifying or retiring them when they no longer add value.
  • Partner with the President and leadership team to evolve the operating model, clarifying roles, interfaces, decision rights, and accountabilities as the organization and portfolio grow.
  • Serve as an operating link between ITF Therapeutics and Italfarmaco, driving alignment across US and corporate priorities, planning, governance, reporting, and decision-making.
  • Represent the President, as appropriate, with the leadership team, functional leaders, and external stakeholders, accurately conveying intent, including difficult messages.
  • Build trusted relationships across functions and facilitate alignment among stakeholders with differing priorities, perspectives, or incentives.
  • Connect work across functions without displacing functional accountability, helping leaders resolve dependencies and make decisions from an enterprise rather than purely functional perspective.

Desired Qualifications

  • An advanced degree in business, life sciences, or a related field, such as an MBA, PharmD, PhD, MPH, or equivalent.
  • Experience operating within a global matrix, ideally with a non-US parent company or global function.
  • Commercial-stage pharmaceutical experience, including product launch.
  • Prior Chief of Staff, business operations, or portfolio management experience.
  • Management consulting experience.

About the Company

ITF Therapeutics

Develops and commercializes rare-disease therapies

ITF Therapeutics is a division of Italfarmaco S.p.A. focused on developing and commercializing treatments for rare diseases in the U.S., especially Duchenne Muscular Dystrophy (DMD). The company works on early-stage research and clinical development, partnering with patient advocacy groups and clinical leaders to align programs with patient needs. Its lead program is DUVYZAT (givinostat), a histone deacetylase (HDAC) inhibitor aimed at DMD. Revenue comes from bringing these specialized therapies to market. Compared with competitors, ITF Therapeutics emphasizes collaboration with patient groups and clinicians, a pipeline-focused early-development approach, and a specialty in HDAC inhibitors for rare diseases. The company’s goal is to deliver effective treatments for rare-disease patients by advancing promising therapies through development and into commercialization.

Company size
1-10
Company stage
Not listed
Total funding
Not listed
Headquarters
Concord, NH
Founded
2024

Recently Posted Jobs

Explore more opportunities at ITF Therapeutics

See more jobs